ArticleBlood2018

Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response.

Sanil Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.